2 assets in Necrotizing Enterocolitis

Therapeutic assets addressing Necrotizing Enterocolitis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
hlx3901 Necrotizing Enterocolitis	Shanghai Henlius Biotech	P1	NR ()
Hydrocortisone Necrotizing Enterocolitis	Coordinación de Investigación en Salud, Mexico	P4	NR ()